ARHGAP5 and hepatocellular carcinoma: The in vivo HCC metastasis results revealed that silencing of ARHGAP5‐AS1 can significantly impair the distant metastasis of the lung and other organs of HCC cells after injection of malignant cells (Figure 3C).